Development of emission factors to estimate discharge of typical pharmaceuticals and personal care products from wastewater treatment plants

https://doi.org/10.1016/j.scitotenv.2020.144556Get rights and content

Highlights

  • A simple approach was proposed for calculation of PPCP emission factors (EFs).

  • EFs focused on biological treatment and disinfection (UV and chlorine) processes.

  • EFs of 9 PPCPs were established for low, medium and high emission scenarios.

  • Mass of 9 PPCPs in the Yangtze River valley was 8808 kg for medium scenario in 2018.

Abstract

Due to the potential ecological and human health risks, pharmaceuticals and personal care products (PPCPs) are considered as contaminants of emerging concern. PPCPs can be discharged to the aquatic environment from various sources, including municipal wastewater treatment plants (WWTPs), animal feeding operations, hospitals, and pharmaceutical manufacturers. A major challenge to regional characterization of ecological and human health risks is identification of the environmental emissions of PPCPs. This study established a facile approach for calculation of PPCP emission factors from raw wastewater and wastewater effluent. Using reported concentrations from WWTPs, nine PPCPs, namely carbamazepine, ciprofloxacin, erythromycin, ibuprofen, ketoprofen, ofloxacin, sulfadiazine, sulfamethoxazole, and trimethoprim, were identified as priority contaminants based on environmental significance (i.e., high detection frequency and potential ecological risk) and data availability. Emission factors were calculated for the nine PPCPs in raw wastewater, secondary effluent, and tertiary effluent for low, medium and high emission scenarios according to the concentration distributions of these nine PPCPs. The emission factors were used to estimate the mass of the PPCPs discharged from the nine provinces and two municipalities of the Yangtze River valley. The total mass of the nine PPCPs emitted into the watershed was estimated as 3867 kg, 8808 kg and 21,464 kg for low, medium and high emission scenarios respectively in 2018. Although uncertainty is inevitable in the emission factors, the reported approach provides a viable alternative to top-down and multimedia fugacity estimation strategies that require an abundance of sewershed-, WWTP-, and compound-specific information that is difficult to collect in developing countries.

Introduction

Pharmaceuticals and personal care products (PPCPs) are necessary to maintain human health and quality of life. While PPCPs improve our lives, these specially-designed molecules are sometimes over-prescribed, overused, and improperly disposed (Zhang et al., 2015b; Zhang et al., 2019). For instance, many PPCPs can be obtained over-the-counter with little restriction in China and other Asian countries (Tran et al., 2018). As a result, relatively high PPCP concentrations have been detected in the following downstream environmental systems: surface water (Barbosa et al., 2018; Ebele et al., 2017; Hopkins and Blaney, 2016; Veras et al., 2019); sediment (da Silva et al., 2011; Xie et al., 2019); soil (Dodgen et al., 2014; Gottschall et al., 2012); domestic, industrial, hospital, and agricultural wastewater (He et al., 2015; Liu et al., 2017; Oliveira et al., 2015; Petrie et al., 2015; Sim et al., 2011; Van Epps and Blaney, 2016); groundwater (Sharma et al., 2019; Sui et al., 2015); landfill leachates (Sui et al., 2017; Yu et al., 2020a; Yu et al., 2020b); and, aquatic organisms (He et al., 2019; He et al., 2017). Wastewater treatment plants (WWTPs) receive a high load of PPCPs due to incomplete metabolism of pharmaceuticals in humans, wash-off of personal care products during/after use, and improper disposal down the drain (Dong et al., 2016a; Michael et al., 2013). Due to their incomplete removal in most WWTPs (He et al., 2015; Verlicchi et al., 2012), a fraction of the PPCPs in raw wastewater is discharged into receiving water bodies.

The emission of PPCPs to the environment causes certain ecological and human health risks, including antibiotic resistance (Gago-Ferrero et al., 2015; Oaks et al., 2004; Wang et al., 2018) and endocrine disruption (Abdel-Moneim et al., 2017; Golden et al., 2008; Wang et al., 2018), among others (Jepsen et al., 2019). More importantly, the discharged PPCPs could also be migrated to further influence the ecosystem of protected area (e.g. Amazon Estuary) (Chaves et al., 2020). To assess downstream ecological impacts, the mass loading of individual PPCPs into the environment must be identified. The most common methods to quantify PPCP concentrations and loads in wastewater effluent involve grab or composite sample collection followed by liquid chromatography with tandem mass spectrometry analysis (Dong et al., 2016b; Subedi et al., 2017; Zhang et al., 2020; Zhong et al., 2019). These techniques are labor-intensive and expensive, making them unsuitable for widespread deployment in developing countries. For this reason, more convenient methods are needed to estimate PPCP emissions to the environment.

To date, two main strategies for estimating PPCP emissions have been explored: top-down approaches (Carballa et al., 2008; Franquet-Griell et al., 2017; Tarpani and Azapagic, 2018; Tran et al., 2018); and, multimedia fugacity models (Khan and Ongerth, 2004; Trinh et al., 2016; Zhang et al., 2015a). Top-down prediction of PPCP concentrations and loads requires knowledge of WWTP capacity (i.e., volumetric flow rate), the population served by the WWTP, and PPCP consumption per capita. For example, predicted environmental concentrations (PECs) of anticancer drugs in Spanish wastewater effluent were calculated using the population, drug consumption data from pharmacies, daily per capita water consumption, drug excretion factors, and previously determined removal efficiencies for the WWTP (Franquet-Griell et al., 2017). Similarly, Carballa et al. (2008) applied four parameters (i.e., population, per capita consumption, excretion factor, and average wastewater flow rate) to determine PECs for pharmaceuticals, fragrances, and hormones. The influent and effluent concentration ranges in WWTPs have also been evaluated with the daily raw wastewater flow rate, sewershed population, and PPCP concentrations from previous studies (to calculate removal efficiency) and used to estimated freshwater concentrations (Tarpani and Azapagic, 2018). Compared with top-down strategies, multimedia fugacity models require media-specific information to calculate PECs for PPCPs (Khan and Ongerth, 2004; Trinh et al., 2016; Zhang et al., 2015a). In addition to the PPCP consumption and population data, the transfer and distribution coefficients of compounds between different phases are needed in these models. Fugacity models have been combined with Geographic Information Systems to estimate PPCP concentrations and emissions within specific catchments (Boxall et al., 2014; Pistocchi et al., 2012). Both top-down and fugacity methods require a great deal of compound-, catchment-, and WWTP-specific information to accurately estimate PPCP emissions; however, this information is often challenging to acquire and update. Given the aforementioned limitations of the top-down and multimedia fugacity modeling approaches, a bottom-up strategy of acquiring PPCP emission factors was investigated. Here, emission factor is defined as the amount of PPCPs discharged for per liter wastewater treated by WWTPs, which is just the PPCPs concentration in WWTP effluent. This simple strategy only required information about the wastewater treatment train to predict PPCP emissions of WWTPs. The PPCP emission through PPCPs can be roughly calculated by emission factors combined with sewage amount.

The main objective of this work was to develop a conceptual framework to predict the mass of PPCPs discharged into the environment based on extensive literature analysis. Emission factors of different PPCPs, as an output of the conceptual framework, were used for subsequent estimation. The emission factors of different scenarios were defined corresponding to different wastewater treatment processes, which were further applied to calculate the environmental discharge of nine PPCPs by WWTPs in Yangtze River valley.

Section snippets

Data collection and PPCP selection

In total, 195 reports (see Table S1 in the Supporting information (SI)) on the occurrence of PPCPs in municipal WWTPs from 1998 to 2020 were collected and analyzed. All the reports are from published papers or literatures to ensure the relative accuracy of data. The municipal WWTPs are required to be stably operated but not conceptual plants or pilot plants. The selected WWTPs were located in 26 countries belong to 5 continents (Asia, Europe, North America, South America and Africa). These

Regional and temporal differences in PPCP concentrations in wastewater

Raw wastewater concentrations of the nine PPCPs of concern ranged from ND to 45,320 ng L−1, while the PPCP concentrations in wastewater effluent were ND – 6840 ng L−1. With the exception of IBU, the average concentrations of the PPCPs in raw wastewater were not statistically different (p > 0.05, one-way ANOVA, as shown in Table S4). IBU is a nonsteroidal anti-inflammatory drug used to reduce pain and inflammation. Among the nine PPCPs, IBU was the highest ranked in terms of total prescriptions

Conclusion

Based on extensive literature analysis of wastewater occurrence data for 392 PPCPs, nine frequently detected contaminants were selected for calculation of emission factors. A new concept for development of PPCP emission factors, namely bottom-up calculation from previously monitored concentrations, was established. The emission factors in low, medium and high emission scenarios were generated for the nine PPCPs to estimate contributions from raw wastewater, secondary effluent, and tertiary

CRediT authorship contribution statement

Wenxing Zhao: Methodology, Software, Validation, Formal analysis, Investigation, Writing – original draft. Gang Yu: Conceptualization, Supervision, Writing – review & editing. Lee Blaney: Writing – review & editing. Bin Wang: Writing – review & editing, Supervision, Funding acquisition.

Declaration of competing interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgements

We thank Prof. Heidelore Fiedler (Örebro University, Sweden) for constructive comments. This work was financially supported by the Major Science and Technology Program for Water Pollution Control and Treatment in China (2017ZX07202006).

References (53)

  • C. Gomez-Canela et al.

    Development of predicted environmental concentrations to prioritize the occurrence of pharmaceuticals in rivers from Catalonia

    Sci. Total Environ.

    (2019)
  • N. Gottschall et al.

    Pharmaceutical and personal care products in groundwater, subsurface drainage, soil, and wheat grain, following a high single application of municipal biosolids to a field

    Chemosphere

    (2012)
  • K. He et al.

    Detection of a wide variety of human and veterinary fluoroquinolone antibiotics in municipal wastewater and wastewater-impacted surface water

    J Pharmaceut Biomed

    (2015)
  • K. He et al.

    Simultaneous determination of UV-filters and estrogens in aquatic invertebrates by modified quick, easy, cheap, effective, rugged, and safe extraction and liquid chromatography tandem mass spectrometry

    J. Chromatogr. A

    (2017)
  • K. He et al.

    Occurrence of antibiotics, estrogenic hormones, and UV-filters in water, sediment, and oyster tissue from the Chesapeake Bay

    Sci. Total Environ.

    (2019)
  • K. He et al.

    Sale-based estimation of pharmaceutical concentrations and associated environmental risk in the Japanese wastewater system

    Environ. Int.

    (2020)
  • Z.R. Hopkins et al.

    An aggregate analysis of personal care products in the environment: identifying the distribution of environmentally-relevant concentrations

    Environ. Int.

    (2016)
  • R. Jepsen et al.

    Effects of antimicrobial exposure on detrital biofilm metabolism in urban and rural stream environments

    Sci. Total Environ.

    (2019)
  • S.J. Khan et al.

    Modelling of pharmaceutical residues in Australian sewage by quantities of use and fugacity calculations

    Chemosphere

    (2004)
  • H.Q. Liu et al.

    Spatial distribution and removal performance of pharmaceuticals in municipal wastewater treatment plants in China

    Sci. Total Environ.

    (2017)
  • I. Michael et al.

    Urban wastewater treatment plants as hotspots for the release of antibiotics in the environment: a review

    Water Res.

    (2013)
  • T.S. Oliveira et al.

    Characterization of Pharmaceuticals and Personal Care products in hospital effluent and waste water influent/effluent by direct-injection LC-MS-MS

    Sci. Total Environ.

    (2015)
  • B. Petrie et al.

    A review on emerging contaminants in wastewaters and the environment: current knowledge, understudied areas and recommendations for future monitoring

    Water Res.

    (2015)
  • A. Pistocchi et al.

    Continental scale inverse modeling of common organic water contaminants in European rivers

    Environ. Pollut.

    (2012)
  • B.H. Schafhauser et al.

    Global review and analysis of erythromycin in the environment: occurrence, bioaccumulation and antibiotic resistance hazards

    Environ. Pollut.

    (2018)
  • B.M. Sharma et al.

    Health and ecological risk assessment of emerging contaminants (pharmaceuticals, personal care products, and artificial sweeteners) in surface and groundwater (drinking water) in the Ganges River Basin, India

    Sci. Total Environ.

    (2019)
  • Cited by (27)

    View all citing articles on Scopus
    View full text